Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

NINDS Recruiting Patients for Phase 2 Idebenone Study

The National Institute of Neurological Disorders and Stroke (NINDS) at NIH is recruting patients for a six month double-blind, placebo-controlled phase 2 clinical trial to determine the safety and efficacy of idebenone administered to patients with Friedreich's Ataxia. NINDS aims to enroll 48 patients composed of children (ages 9-11) and adolescents (ages 12-17) with FA divided evenly among 4 treatment arms (placebo, "low", "intermediate", and "high" dose idebenone).

About the Author

Jen Farmer

Jen Farmer

Executive Director

SHARE

FacebookTwitterLinkedInYoutube
Event C.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News